Brain Co‐Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy

Red blood cell membrane-camouflaged nanoparticles loaded with AIEgen and Poly(I: C) for enhanced tumoral photodynamic-immunotherapy

(2021) Jun Dai et al.   National Science Review

Exploiting the acquired vulnerability of cisplatin-resistant tumors with a hypoxia-amplifying DNA repair–inhibiting (HYDRI) nanomedicine

(2021) Jing Chen et al.   Science Advances

Targeted Noninvasive Treatment of Choroidal Neovascularization by Hybrid Cell-Membrane-Cloaked Biomimetic Nanoparticles

(2021) Manjing Li et al.   ACS Nano

Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier

(2021) Jia Li et al.   Advanced Science

Genetically engineered cell membrane–coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs

(2021) Joon Ho Park et al.   Science Advances

Camouflaging Nanoparticles with Brain Metastatic Tumor Cell Membranes: A New Strategy to Traverse Blood–Brain Barrier for Imaging and Therapy of Brain Tumors

(2020) Caixia Wang et al.   ADVANCED FUNCTIONAL MATERIALS

First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide

(2020) Nobuhiro Hata et al.   JOURNAL OF NEURO-ONCOLOGY

Safety and feasibility of multiple blood-brain barrier disruptions for the treatment of glioblastoma in patients undergoing standard adjuvant chemotherapy

(2020) So Hee Park et al.   JOURNAL OF NEUROSURGERY

Overcoming blood–brain barrier transport: Advances in nanoparticle-based drug delivery strategies

(2020) Shichao Ding et al.   Materials Today

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma

(2020) Chenfei Lu et al.   Molecular Cancer

Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy

(2020) Yanjie Liu et al.   NANO LETTERS

Blood-triggered generation of platinum nanoparticle functions as an anti-cancer agent

(2020) Xin Zeng et al.   Nature Communications

Tackling the Many Facets of Glioblastoma Heterogeneity

(2020) Itay Tirosh et al.   Cell Stem Cell

Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis

(2020) Lina Marenco-Hillembrand et al.   JOURNAL OF NEURO-ONCOLOGY

Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal

(2020) Elana Ben-Akiva et al.   Science Advances

Biomimetic Nanocomposites Cloaked with Bioorthogonally Labeled Glioblastoma Cell Membrane for Targeted Multimodal Imaging of Brain Tumors

(2020) Yukun Duan et al.   ADVANCED FUNCTIONAL MATERIALS

Management of glioblastoma: State of the art and future directions

(2020) Aaron C. Tan et al.   CA-A CANCER JOURNAL FOR CLINICIANS

RACK7 recognizes H3.3G34R mutation to suppress expression of MHC class II complex components and their delivery pathway in pediatric glioblastoma

(2020) Fangfang Jiao et al.   Science Advances

Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis

(2020) Ann Taber et al.   Nature Communications

Tumor repolarization by an advanced liposomal drug delivery system provides a potent new approach for chemo-immunotherapy

(2020) L. Ringgaard et al.   Science Advances

Cell Membrane-Covered Nanoparticles as Biomaterials

(2019) Mingjun Xuan et al.   National Science Review

Deciphering the complex role of thrombospondin-1 in glioblastoma development

(2019) Thomas Daubon et al.   Nature Communications

Engineered Mesenchymal Stem Cell/Nanomedicine Spheroid as an Active Drug Delivery Platform for Combinational Glioblastoma Therapy

(2019) Smruthi Suryaprakash et al.   NANO LETTERS

A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma

(2019) Jiayi Huang et al.   JOURNAL OF NEURO-ONCOLOGY

Compressive tumours cause neuronal damage

(2019) Paul A. Janmey et al.   Nature Biomedical Engineering

Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39

(2019) Maisa C. Takenaka et al.   NATURE NEUROSCIENCE

Cisplatin: The first metal based anticancer drug

(2019) Sumit Ghosh   BIOORGANIC CHEMISTRY

An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

(2019) Cyril Neftel et al.   CELL

Tumor-Derived Extracellular Vesicles Breach the Intact Blood–Brain Barrier via Transcytosis

(2019) Golnaz Morad et al.   ACS Nano

Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival

(2019) Mohummad Aminur Rahman et al.   BRITISH JOURNAL OF CANCER

Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination

(2018) Rong Yang et al.   ACS Nano

Cell Membrane Coating Nanotechnology

(2018) Ronnie H. Fang et al.   ADVANCED MATERIALS

Repair gene O6 -methylguanine-DNA methyltransferase is controlled by SP1 and up-regulated by glucocorticoids, but not by temozolomide and radiation

(2018) Dorthe Aasland et al.   JOURNAL OF NEUROCHEMISTRY

Current state of immunotherapy for glioblastoma

(2018) Michael Lim et al.   Nature Reviews Clinical Oncology

Nanotechnology-Based Strategies for siRNA Brain Delivery for Disease Therapy

(2018) Meng Zheng et al.   TRENDS IN BIOTECHNOLOGY

Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles

(2018) Fred C. Lam et al.   Nature Communications

A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma

(2018) Xiaoyue Chen et al.   Nature Communications

Phototheranostics: Active Targeting of Orthotopic Glioma Using Biomimetic Proteolipid Nanoparticles

(2018) Yali Jia et al.   ACS Nano

Effective and Targeted Human Orthotopic Glioblastoma Xenograft Therapy via a Multifunctional Biomimetic Nanomedicine

(2018) Yan Zou et al.   ADVANCED MATERIALS

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma

(2017) Roger Stupp et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patients

(2017) Yu Wang et al.   MEDICINE

Cisplatin is retained in the cochlea indefinitely following chemotherapy

(2017) Andrew M. Breglio et al.   Nature Communications

Targeting NF- B in glioblastoma: A therapeutic approach

(2016) D. Friedmann-Morvinski et al.   Science Advances

O6-methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma

(2015) Shang Hung Chen et al.   INTERNATIONAL JOURNAL OF CANCER

Cisplatin in cancer therapy: Molecular mechanisms of action

(2014) Shaloam Dasari et al.   EUROPEAN JOURNAL OF PHARMACOLOGY